TrialThe Lancet. Haematology2024

Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia: a phase 2 study.

Alexandre Bazinet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.